The period around birth is a risky time for stroke in infants, which is associated with two major acute and subacute processes: anatomical damage and seizures. It is unclear as to what extent each of these processes independently contributes to poor outcome. Furthermore, it is unclear whether there is an interaction between the two processes - does seizure activity cause additional brain damage beyond that produced by ischemia and/or does brain damage foster seizures? The model of focal cerebral ischemia induced by the intrahippocampal infusion of endothelin-1 (ET-1) in 12-day-old rat was used to examine the role of the endothelin receptors in the development of focal ischemia, symptomatic acute seizures and neurodegeneration. ET-1 (40pmol/μl) was infused either alone or co-administered with selective antagonists of ETA (BQ123; 70nmol/μl) or ETB receptors (BQ788; 70nmol/1μl). Effects of activation of ETB receptors were studied using selective agonist 4-Ala-ET-1 (40pmol/1μl). Regional cerebral blood flow (rCBF) and tissue oxygenation (pO2) were measured in anesthetized animals with a Doppler-flowmeter and a pO2-sensor, respectively. Seizure development was assessed with video-EEG in freely moving rats. Controls received the corresponding volume of the appropriate vehicle (10mM PBS or 0.01% DMSO-PBS solution; pH7.4). The extent of hippocampal lesion was determined using FluoroJade B staining performed 24h after ET-1 infusion. Infusion of ET-1 or ET-1+ETB receptor antagonist reduced rCBF to ~25% and pO2 to ~10% for about 1.5h, whereas selective ETB agonist, ET-1+ETA antagonist and the PBS vehicle had only negligible effect on the rCBF and pO2 levels. Reduction of rCBF was associated with the development of lesion in the injected hippocampus. In all groups, except sham operated and PBS controls, epileptiform activity was observed after activation of the ETA or the ETB receptors. The data revealed a positive correlation between the severity of morphological damage and all the measured seizure parameters (seizure frequency, average and total seizure duration) in the ET-1 group. In addition, the severity of morphological damage positively correlated with the average seizure duration in animals after infusion of ET-1+ETA receptor antagonist or after infusion of ET-1+ETB receptor antagonist. Our results indicate that the activation of ETA receptors is crucial for ischemia development, however either ETA or ETB receptors mediate the development of seizures following the application of ET-1 in immature rats. The dissociation between the ischemic-producing and seizure-producing processes suggests that damage is not necessary to induce seizures, although it may exacerbate them.

Department of Developmental Epileptology Institute of Physiology v v i Academy of Sciences of the Czech Republic Videnska 1083 Prague CZ 14220 Czech Republic

Strong Epilepsy Center Department of Neurology University of Rochester Medical Center 601 Elmwood Avenue Box 673 Rochester NY 14642 USA

000      

00000naa a2200000 a 4500

001      

bmc15022889

003      

CZ-PrNML

005      

20150728110310.0

007      

ta

008      

150709s2015 xxu f 000 0|eng||

009      

AR

024    7_

$a 10.1016/j.expneurol.2014.12.017 $2 doi

035    __

$a (PubMed)25542981

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxu

100    1_

$a Tsenov, Grygoriy $u Department of Developmental Epileptology, Institute of Physiology, v.v.i., Academy of Sciences of the Czech Republic, Videnska 1083, Prague CZ-14220, Czech Republic. Electronic address: grygoriy.tsenov@gmail.com.

245    10

$a Activation of either the ETA or the ETB receptors is involved in the development of electrographic seizures following intrahippocampal infusion of the endothelin-1 in immature rats / $c G. Tsenov, K. Vondrakova, J. Otahal, J. Burchfiel, H. Kubova,

520    9_

$a The period around birth is a risky time for stroke in infants, which is associated with two major acute and subacute processes: anatomical damage and seizures. It is unclear as to what extent each of these processes independently contributes to poor outcome. Furthermore, it is unclear whether there is an interaction between the two processes - does seizure activity cause additional brain damage beyond that produced by ischemia and/or does brain damage foster seizures? The model of focal cerebral ischemia induced by the intrahippocampal infusion of endothelin-1 (ET-1) in 12-day-old rat was used to examine the role of the endothelin receptors in the development of focal ischemia, symptomatic acute seizures and neurodegeneration. ET-1 (40pmol/μl) was infused either alone or co-administered with selective antagonists of ETA (BQ123; 70nmol/μl) or ETB receptors (BQ788; 70nmol/1μl). Effects of activation of ETB receptors were studied using selective agonist 4-Ala-ET-1 (40pmol/1μl). Regional cerebral blood flow (rCBF) and tissue oxygenation (pO2) were measured in anesthetized animals with a Doppler-flowmeter and a pO2-sensor, respectively. Seizure development was assessed with video-EEG in freely moving rats. Controls received the corresponding volume of the appropriate vehicle (10mM PBS or 0.01% DMSO-PBS solution; pH7.4). The extent of hippocampal lesion was determined using FluoroJade B staining performed 24h after ET-1 infusion. Infusion of ET-1 or ET-1+ETB receptor antagonist reduced rCBF to ~25% and pO2 to ~10% for about 1.5h, whereas selective ETB agonist, ET-1+ETA antagonist and the PBS vehicle had only negligible effect on the rCBF and pO2 levels. Reduction of rCBF was associated with the development of lesion in the injected hippocampus. In all groups, except sham operated and PBS controls, epileptiform activity was observed after activation of the ETA or the ETB receptors. The data revealed a positive correlation between the severity of morphological damage and all the measured seizure parameters (seizure frequency, average and total seizure duration) in the ET-1 group. In addition, the severity of morphological damage positively correlated with the average seizure duration in animals after infusion of ET-1+ETA receptor antagonist or after infusion of ET-1+ETB receptor antagonist. Our results indicate that the activation of ETA receptors is crucial for ischemia development, however either ETA or ETB receptors mediate the development of seizures following the application of ET-1 in immature rats. The dissociation between the ischemic-producing and seizure-producing processes suggests that damage is not necessary to induce seizures, although it may exacerbate them.

650    _2

$a zvířata $7 D000818

650    12

$a elektroencefalografie $x účinky léků $7 D004569

650    _2

$a endotelin-1 $x aplikace a dávkování $x toxicita $7 D019332

650    _2

$a hipokampus $x účinky léků $x metabolismus $7 D006624

650    _2

$a injekce intraventrikulární $7 D007276

650    _2

$a mužské pohlaví $7 D008297

650    _2

$a krysa rodu Rattus $7 D051381

650    _2

$a potkani Wistar $7 D017208

650    _2

$a receptor endotelinu A $x agonisté $x metabolismus $7 D044022

650    _2

$a receptor endotelinu B $x agonisté $x metabolismus $7 D044023

650    _2

$a záchvaty $x chemicky indukované $x metabolismus $7 D012640

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Vondrakova, Katerina $u Department of Developmental Epileptology, Institute of Physiology, v.v.i., Academy of Sciences of the Czech Republic, Videnska 1083, Prague CZ-14220, Czech Republic.

700    1_

$a Otahal, Jakub $u Department of Developmental Epileptology, Institute of Physiology, v.v.i., Academy of Sciences of the Czech Republic, Videnska 1083, Prague CZ-14220, Czech Republic.

700    1_

$a Burchfiel, James $u Strong Epilepsy Center, Department of Neurology, University of Rochester Medical Center, 601 Elmwood Avenue, Box 673, Rochester, NY 14642, USA.

700    1_

$a Kubova, Hana $u Department of Developmental Epileptology, Institute of Physiology, v.v.i., Academy of Sciences of the Czech Republic, Videnska 1083, Prague CZ-14220, Czech Republic.

773    0_

$w MED00001749 $t Experimental neurology $x 1090-2430 $g Roč. 265, č. - (2015), s. 40-7

856    41

$u https://pubmed.ncbi.nlm.nih.gov/25542981 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20150709 $b ABA008

991    __

$a 20150728110355 $b ABA008

999    __

$a ok $b bmc $g 1083228 $s 905882

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2015 $b 265 $c - $d 40-7 $i 1090-2430 $m Experimental neurology $n Exp Neurol $x MED00001749

LZP    __

$a Pubmed-20150709